Sunday, September 30, 2018

Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to new data.

from Top Health News -- ScienceDaily https://ift.tt/2QmSzBG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Scientists discover what triggers belly fat as we age

Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery re...